Stay updated with breaking news from Access Segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VANCOUVER, British Columbia, Oct. 12, 2023 -- Mydecine Innovations Group, Inc. , a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly...
The Company has completed its admission to the Access segment of the AQSE Growth Market and trading will commence at 8:00 A.M. GM - Oct 10, 2023 -
DUBLIN--(BUSINESS WIRE)--Oct 9, 2023--
Switch to Euronext Paris Growth segment: details of operation 04 Oct 2023 16:41 CEST Subscribe ...
VANCOUVER, British Columbia, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF)...